Cancer Treatment Continuation Study

We are offering ongoing treatment for cancer patients who participated in earlier studies. This study checks the safety of the therapy while ensuring patients have access to their treatment.

>2 years Confirmation phase (III)Post-Trial Drug Access No Placebo Cost Reimbursement Partially Remote Investigational Medicines Oral InjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Abiraterone

Abiraterone is a medicine used to treat prostate cancer by lowering male hormones that can make the cancer grow.

Avastin

Avastin is a cancer medicine used to slow tumor growth by stopping tumors from getting new blood vessels.

Rozlytrek

Rozlytrek is a cancer medicine used to treat certain lung and other tumors that have specific gene changes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Abiraterone

Abiraterone is a substance that reduces testosterone production to help manage advanced prostate cancer.

Abiraterone Acetate

Abiraterone acetate is a substance that lowers the body's male hormones to slow the growth of prostate cancer.

Atezolizumab

Atezolizumab is a substance that helps the immune system recognize and attack certain cancers by blocking a protein called PD-L1.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Ipatasertib

Inavolisib

Tiragolumab

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abaxan

Abevmy

Abibam®

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Grand Hopital De Charleroi

Oncology

Gilly, Belgium

UZ Leuven

Oncology

Heverlee, Belgium

Algemeen Ziekenhuis Groeninge

Urology

Kortrijk, Belgium

Sponsor: F. Hoffmann-La Roche AG

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.